Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage: ANNEXA-4 Substudy

MLA

Demchuk, A. M., et al. “Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage: ANNEXA-4 Substudy.” Stroke, 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1294271845&authtype=sso&custid=ns315887.

APA

Demchuk, A. M., Yue, P., Zotova, E., Nakamya, J., Xu, L., Milling, T. J., Jr., Ohara, T., Goldstein, J. N., Middeldorp, S., Verhamme, P., Lopez-Sendon, J. L., Conley, P. B., Curnutte, J. T., Eikelboom, J. W., Crowther, M., & Connolly, S. J. (2021). Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage: ANNEXA-4 Substudy. Stroke.

Chicago

Demchuk, A.M., P. Yue, E. Zotova, J. Nakamya, L. Xu, T.J. Milling Jr., T. Ohara, et al. 2021. “Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage: ANNEXA-4 Substudy.” Stroke. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1294271845&authtype=sso&custid=ns315887.